Recent studies suggest that the Shingrix vaccine against herpes zoster may reduce the risk of developing dementia and Alzheimer’s disease by 20%, raising the question of whether this vaccination should be recommended for people over 65 years old. #VaccinZona #MaladieAlzheimer #SantéSenior (translated)
